Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Prognosis of schizophrenia in persons with and without a history of cannabis use.

Manrique-Garcia E, Zammit S, Dalman C, Hemmingsson T, Andreasson S, Allebeck P.

Psychol Med. 2014 Sep;44(12):2513-21. doi: 10.1017/S0033291714000191.

2.

Cannabis, schizophrenia and other non-affective psychoses: 35 years of follow-up of a population-based cohort.

Manrique-Garcia E, Zammit S, Dalman C, Hemmingsson T, Andreasson S, Allebeck P.

Psychol Med. 2012 Jun;42(6):1321-8. doi: 10.1017/S0033291711002078. Epub 2011 Oct 17.

PMID:
21999906
3.

Intensive care unit survivors have fewer hospital readmissions and readmission days than other hospitalized patients in British Columbia.

Keenan SP, Dodek P, Chan K, Simon M, Hogg RS, Anis AH, Spinelli JJ, Tilley J, Norena M, Wong H.

Crit Care Med. 2004 Feb;32(2):391-8.

PMID:
14758153
4.

[Cannabis and schizophrenia: demographic and clinical correlates].

Dervaux A, Laqueille X, Bourdel MC, Leborgne MH, Olié JP, Lôo H, Krebs MO.

Encephale. 2003 Jan-Feb;29(1):11-7. French.

PMID:
12640322
5.
6.

Adverse events during medical and surgical hospitalizations for persons with schizophrenia.

Daumit GL, Pronovost PJ, Anthony CB, Guallar E, Steinwachs DM, Ford DE.

Arch Gen Psychiatry. 2006 Mar;63(3):267-72.

PMID:
16520431
7.

A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: implications for the concept of cannabis psychosis.

Boydell J, Dean K, Dutta R, Giouroukou E, Fearon P, Murray R.

Schizophr Res. 2007 Jul;93(1-3):203-10. Epub 2007 Apr 25.

PMID:
17462864
8.

Length of hospital stay and 30-day readmission following heart failure hospitalization: insights from the EVEREST trial.

Khan H, Greene SJ, Fonarow GC, Kalogeropoulos AP, Ambrosy AP, Maggioni AP, Zannad F, Konstam MA, Swedberg K, Yancy CW, Gheorghiade M, Butler J; EVEREST Trial Investigators.

Eur J Heart Fail. 2015 Oct;17(10):1022-31. doi: 10.1002/ejhf.282. Epub 2015 May 9.

9.

Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study.

Zammit S, Allebeck P, Andreasson S, Lundberg I, Lewis G.

BMJ. 2002 Nov 23;325(7374):1199.

10.

Risk factors for early readmission to acute care for persons with schizophrenia taking antipsychotic medications.

Boaz TL, Becker MA, Andel R, Van Dorn RA, Choi J, Sikirica M.

Psychiatr Serv. 2013 Dec 1;64(12):1225-9. doi: 10.1176/appi.ps.003382012.

PMID:
23945797
11.
12.

Early non-adherence to medication and other risk factors for rehospitalization in schizophrenia and schizoaffective disorder.

Bodén R, Brandt L, Kieler H, Andersen M, Reutfors J.

Schizophr Res. 2011 Dec;133(1-3):36-41. doi: 10.1016/j.schres.2011.08.024. Epub 2011 Oct 5.

PMID:
21982098
13.

Five-year follow-up of an acute psychiatric admission cohort in Auckland, New Zealand.

Wheeler A, Moyle S, Jansen C, Robinson E, Vanderpyl J.

N Z Med J. 2011 Jun 10;124(1336):30-8.

PMID:
21946742
14.

[Heavy users in a psychiatric hospital--a cohort study on 1811 patients over five years].

Spiessl H, Hübner-Liebermann B, Binder H, Cording C.

Psychiatr Prax. 2002 Oct;29(7):350-4. German.

PMID:
12378415
15.

Risk factors for readmission of orthopaedic surgical patients.

Dailey EA, Cizik A, Kasten J, Chapman JR, Lee MJ.

J Bone Joint Surg Am. 2013 Jun 5;95(11):1012-9. doi: 10.2106/JBJS.K.01569.

PMID:
23780539
16.

Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.

Stargardt T, Weinbrenner S, Busse R, Juckel G, Gericke CA.

J Ment Health Policy Econ. 2008 Jun;11(2):89-97.

PMID:
18509216
17.

Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases.

Arendt M, Rosenberg R, Foldager L, Perto G, Munk-Jørgensen P.

Br J Psychiatry. 2005 Dec;187:510-5.

18.

The short mean length of stay of post-emergency geriatric units is associated with the rate of early readmission in frail elderly.

Traissac T, Videau MN, Bourdil MJ, Bourdel-Marchasson I, Salles N.

Aging Clin Exp Res. 2011 Jun;23(3):217-22.

PMID:
21993169
20.

Schizophrenia in users and nonusers of cannabis. A longitudinal study in Stockholm County.

Andréasson S, Allebeck P, Rydberg U.

Acta Psychiatr Scand. 1989 May;79(5):505-10.

PMID:
2787581

Supplemental Content

Support Center